• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 211/14 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Patent holdings for IPC class C07D 211/14

Total number of patents in this class: 392

10-year publication summary

20
25
24
20
24
25
20
23
22
20
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nocion Therapeutics, Inc.
47
9
Bristol-myers Squibb Company
4867
7
Incyte Corporation
1027
7
University of Pittsburgh - Of the Commonwealth System of Higher Education
3183
7
Incyte Holdings Corporation
665
6
Janssen Pharmaceutica N.V.
3369
5
Centre National de La Recherche Scientifique
10516
5
Massachusetts Institute of Technology
10102
5
Cassava Science, Inc.
13
5
BASF SE
20979
4
Immunomet Therapeutics Inc.
31
4
Modernatx, Inc.
1284
4
Toyama Chemical Co., Ltd.
101
4
Anji Pharmaceuticals Inc.
34
4
Etherna Immunotherapies NV
60
4
Libra Therapeutics, Inc.
10
4
Boehringer Ingelheim International GmbH
4642
3
Chevron U.S.A. Inc.
3984
3
JSR Corporation
2525
3
Chong Kun Dang Pharmaceutical Corp.
236
3
Other owners 296